Category: Business

An Alphabet Soup of Financial Designations

Last Saturday, a record 250,000 people around
the world sat to take one of the grueling 6-hour-long exams offered in the CFA®
program, which is 11% more than last year. With a 10-year average pass rate of
44%, these exams are widely considered to be among the toughest in the
industry. Worst of all, you need to pass three levels of exams before you’re
eligible to hold the Chartered Financial Analyst® (CFA). The exams are offered
only once (or twice for the first level) a year, so it can take the better half
of a decade to get through all of them. But the CFA® designation is only one of
the growing number of professional designations in the financial industry. The
proliferation of professional designations has sparked a debate on the value
that these programs bring to the industry. In some ways, the number and variety
of designations have had a dilutive effect on the perception of their value.
Many of the CFA® candidates last Saturday, who were sitting in their testing
center staring down the barrel of a 120-question exam on a perfectly sunny
summer weekend day, must have been wondering, “Is this really worth it?”

Tanker Attacked in the Persian Gulf; Here’s why this time is
different. The incident is one in a long history of sabotage activity in the area and threats to shut down the shipping channel. Previous incidents eventually faded into memory with oil prices returning to pre-existing levels. This time may be different. More

What does CAR-T therapy consist of, what is it and could it
be viewed as a “living anti-cancer drug”? The medicine itself consists of a living cell, which is genetically engineered to find and destroy cancer cells. Chimeric Antigen Receptor T cell therapy (CAR-T) is a gene therapy designed to… More

Noble Capital Markets’ sixteenth annual investor conference – Noble Capital Markets’ plans are set for its sixteenth annual NobleCon investor conference to be held at the New Hard Rock, South Florida, February 2020. More

Great Lakes Dredge & Dock (GLDD) Two New Awards Bolster Confidence in 2019 Outlook. More

IPO Podcast Episode 2: Drug Disruption. Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) probes into the positive aspects of being “disruptive” in healthcare. Changing what is viewed as the norm – disrupting the status quo -can result in very positive change… Like Uber and Airbnb. Here Brant looks for disruption in healthcare; ways to reduce the costs associated with prescription drugs. He interviews the CEO of Dyadic International who believes his company has the answer. You be the judge. More

One Stop Systems (OSS) Can OSS Make Up for the First Quarter Miss? More

Cumulus Media (CMLS) It’s Expected To Get A Little Noisy.
More

Dyadic International (DYAI) Putting Recent Developments Into Perspective. More

Tegna, Inc. (TGNA) Eye on 2020. More

Trovagene Inc. (TROV) Data Rich Year Ahead. More

INITIATION – Electrocore (ECOR) Small Piece of Migraine Market Could be a Big Deal. More

Could the commercial success of cell cycle regulators lead to broadening
developmental pipeline and the importance of CDKs (cyclin-dependent kinases). Cell proliferation is a tightly regulated process by the cell cycle machinery in normal tissues… More

Who will sit on the oil throne? On April 12th, Chevron Corp agreed to buy Anadarko Petroleum Corp for $50 billion including debt.  The acquisition would make Chevron as big as Exxon and Shell and double down its position in the Permian Oil Basin…
More

IPO Podcast Episode 2: Drug Disruption. Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) probes into the positive aspects of being “disruptive” in healthcare. Changing what is viewed as the norm – disrupting the status quo -can result in very positive change… Like Uber and Airbnb. Here Brant looks for disruption in healthcare; ways to reduce the costs associated with prescription drugs. He interviews the CEO of Dyadic International who believes his company has the answer. You be the judge. More

1-800-Flowers.com, Inc 
(FLWS) Winning Doesn’t Get Boring. More

Great Lakes Dredge & Dock (GLDD) Third Strong Quarter in
a Row – 2019 Off to a Great Start. More

INITIATION – Genprex Inc (GNPX) Poised to Emerge as a Leader in Cancer
Gene Therapy. More

Did the Tax Cuts and Jobs Act Reduce People’s Federal Taxes? Was
your tax refund what you hoped it would be? The stories are commonplace in the
news and on social media: the taxpayer who either received less of a refund in
2019 compared to what they received in 2018 or, even worse, went from receiving
a refund in 2018 to having to write a check for taxes owed in 2019. More

What’s the deal with enterprise blockchain? How are
businesses using blockchain? Businesses are finding that blockchain, the
technology behind Bitcoin and other cryptocurrencies, has far wider and more
useful applications than creating speculative digital currency markets. More

IPO Podcast Episode 2: Drug Disruption. Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) probes into the positive aspects of being “disruptive” in healthcare. Changing what is viewed as the norm – disrupting the status quo -can result in very positive change… Like Uber and Airbnb. Here Brant looks for disruption in healthcare; ways to reduce the costs associated with prescription drugs. He interviews the CEO of Dyadic International who believes his company has the answer. You be the judge. More

Sierra Metals Reports Q1-2019 Financial Results at Its
Sociedad Minera Corona Subsidiary in Peru. More

Avino Silver & Gold Mines Ltd. (ASM) Bralorne Exploration Provides Some Reasons for Optimism. More

Sierra Metals (SMTS) How Does The Worker Strike Affect 2019 Production Expectations? More

Vectrus Inc. (VEC) What’s Next Following A Big Win? More

Should the U.S. Uranium Industry Be Rescued? Are Uranium
Trade Sanctions Justified? On April 14, 2019, the U.S. Department of Commerce
(DOC) submitted a report to the White House on their investigation into the
impacts of uranium imports on U.S. national security. More

Take from the rich and give to the politicians. Does A 70% top
marginal tax rate make sense? In an interview on 60 Minutes, Congresswoman
Alexandria Ocasio-Cortez asserted that it’s worth considering to help pay for
new federal programs like the “Green New Deal.” More

IPO Podcast Episode 2: Drug Disruption. Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) probes into the positive aspects of being “disruptive” in healthcare. Changing what is viewed as the norm – disrupting the status quo -can result in very positive change… Like Uber and Airbnb. Here Brant looks for disruption in healthcare; ways to reduce the costs associated with prescription drugs. He interviews the CEO of Dyadic International who believes his company has the answer. You be the judge. More

Comtech Announces Claro Argentina Selected Heights™
Networking Platform for Mobile Backhaul Infrastructure. More

DLH to Announce Second Quarter FY19 Financial Results. More

KeyW’s stock soars after Jacobs Engineering buyout deal at
43% premium. More

Aurania Announces the Appointment of Tony Wood as CFO &
Enters into a $3 Million Loan Agreement with Chairman and CEO. More

Gannett Sets the Record Straight Regarding MNG’s False and
Misleading Statements. More

Sierra Metals (SMTS) What will drive expansion in 2019? More

Albany International Corp. (AIN) New CFO appointment: What does it signal? More

The NEW podcast series, from top-trending iTunes host, Brant Pinvidic, features celebrity CEOs of iconic brands you know and love, to the emerging growth companies and entrepreneurs you should be talking about. The most innovative Ideas, the inspirational People behind them, and the wealth of Opportunities they create… that’s IPO from Channelchek. More

Salem’s radio station sell-off
reduces debt. “Michael Kupinski, director of research at Noble Capital Markets,
Inc. in Boca Raton, Fla., believes the soft first quarter guidance should not
be a trend for the company…” More

Trovagene, Inc. (TROV), a clinical-stage oncology therapeutics company news: Phase 1b/2 dose escalation trial of Onvansertib in Relapsed/Refractory AML demonstrates safety, tolerability and relative durability with complete responses at highest dose levels. More

Endeavour Silver (EXK), a mid-tier precious metals mining company that owns and operates four high-grade, underground, silver-gold mines in Mexico, achieves commercial production at El Compas mine… More

Energy Fuels (UUUU), a leading US-based uranium mining company, supplying U₃O₈ to major nuclear utilities, provides an update on Vanadium production. More

Betting on The Future of Copper. The case for Dr. Copper: new sources of demand are positive for copper. Demand for copper is poised to benefit from greater usage for electric vehicles, communications and clean energy systems, such as solar thermal plants…  More

The NEW podcast series, from top-trending iTunes host, Brant Pinvidic, features celebrity CEOs of iconic brands you know and love, to the emerging growth companies and entrepreneurs you should be talking about. The most innovative Ideas, the inspirational People behind them, and the wealth of Opportunities they create… that’s IPO from Channelchek.

CLICK HERE TO WATCH THE TRAILER

Upcoming episodes – first episode this Thursday

Kathy Ireland: From Supermodel, to socks, to mega-success (and a few failures along the way).

Christie Hefner: The best person for the job… running Playboy Enterprises for almost as long as Hef himself!

Artificial Intelligence: Could a person who is born 10 years from now, live to 120? Billionaires are banking on it.

The science of Investing in Biotechs: A world-class scientific advisory board (SAB) helps you steer through this formidable minefield.

David Weild IV: How the father of the JOBS ACT sees the future for emerging growth companies.

High on Expectations

(Note: related companies are at base of the
story and all the sources listed in the “Balanced” section)

Recently, Canopy Growth Corp (CGC), the Ontario-based cannabis producer, reported a remarkable spike in revenue driven by the company’s first sales of recreational marijuana following recreational legalization in Canada last October. During last quarter, Canopy nearly tripled its quarterly revenue over last year selling 22,271 pounds of weed, 73% of which was recreational. Canopy first made history in 2014 as the first cannabis company to be publicly traded in North America. Since then, Canopy grew to become world’s largest marijuana company by market cap at about $15.2 billion as of market close February 22nd. Canopy, however, is truly only the tip of the iceberg.

The international trend toward legalization combined
with the tremendous amount of investor interest has inspired emerging companies
to bring new products and technologies to market at an exponential rate. The
public small/micro-cap space abounds with unique investment opportunities in
countless emerging cannabis-related markets including pharmaceuticals, cannabidiol
(CBD), hemp, edibles, beverages, vaping equipment, automated joint-rollers, and
everything else you can imagine. Indeed, we stand at the precipice of a
revolution in marijuana consumer and health products.

WATCH IT NOW